Works matching IS 18696953 AND DT 2025 AND VI 16 AND IP 2
Results: 12
Use of Cardioprotective Adjuncts in Type 1 Diabetes.
- Published in:
- Diabetes Therapy, 2025, v. 16, n. 2, p. 145, doi. 10.1007/s13300-024-01687-3
- By:
- Publication type:
- Article
Characteristics and Dosing Patterns of Tirzepatide Users with Type 2 Diabetes in the United States.
- Published in:
- Diabetes Therapy, 2025, v. 16, n. 2, p. 307, doi. 10.1007/s13300-024-01684-6
- By:
- Publication type:
- Article
Experience of People with Diabetes Treated with Insulin Delivery Systems in France: A Comparative Analysis of Multiple Daily Injections, Tubeless Pumps, Tubed Pumps, and Hybrid Closed Loops.
- Published in:
- Diabetes Therapy, 2025, v. 16, n. 2, p. 289, doi. 10.1007/s13300-024-01682-8
- By:
- Publication type:
- Article
Association of Polypharmacy and Burden of Comorbidities on COVID-19 Adverse Outcomes in People with Type 1 or Type 2 Diabetes.
- Published in:
- Diabetes Therapy, 2025, v. 16, n. 2, p. 241, doi. 10.1007/s13300-024-01681-9
- By:
- Publication type:
- Article
The Impact of Age and Sex on Fasting Plasma Glucose and Glycated Haemoglobin (HbA1c) in the Non-diabetes Population.
- Published in:
- Diabetes Therapy, 2025, v. 16, n. 2, p. 257, doi. 10.1007/s13300-024-01680-w
- By:
- Publication type:
- Article
AUGMENTed Real-World Data Enhances Comparative Efficacy Between Once-Weekly Insulin Icodec with Dosing Guide App Versus Once-Daily Insulin Glargine U300 in Insulin-Naive Type 2 Diabetes.
- Published in:
- Diabetes Therapy, 2025, v. 16, n. 2, p. 227, doi. 10.1007/s13300-024-01679-3
- By:
- Publication type:
- Article
Cardiovascular Events in Adults with Type 2 Diabetes and ASCVD Initiating Once-Weekly Semaglutide vs DPP-4is in the USA.
- Published in:
- Diabetes Therapy, 2025, v. 16, n. 2, p. 187, doi. 10.1007/s13300-024-01678-4
- By:
- Publication type:
- Article
Cost-Effectiveness of FreeStyle Libre for Glucose Self-Management Among People with Diabetes Mellitus: A Canadian Private Payer Perspective.
- Published in:
- Diabetes Therapy, 2025, v. 16, n. 2, p. 169, doi. 10.1007/s13300-024-01677-5
- By:
- Publication type:
- Article
Integrating Polygenic Risk Scores (PRS) for Personalized Diabetes Care: Advancing Clinical Practice with Tailored Pharmacological Approaches.
- Published in:
- Diabetes Therapy, 2025, v. 16, n. 2, p. 149, doi. 10.1007/s13300-024-01676-6
- By:
- Publication type:
- Article
A Bioequivalence Study of Two Formulations of Oral Semaglutide in Healthy Participants.
- Published in:
- Diabetes Therapy, 2025, v. 16, n. 2, p. 269, doi. 10.1007/s13300-024-01674-8
- By:
- Publication type:
- Article
Clinical Profile and Treatment Adherence in Patients with Type 2 Diabetes and Chronic Kidney Disease Who Initiate an SGLT2 Inhibitor: A Multi-cohort Study.
- Published in:
- Diabetes Therapy, 2025, v. 16, n. 2, p. 205, doi. 10.1007/s13300-024-01671-x
- By:
- Publication type:
- Article
A Podcast on Patient and Physician Perspectives in the Holistic Care of Heart-Related Challenges of Type 2 Diabetes.
- Published in:
- Diabetes Therapy, 2025, v. 16, n. 2, p. 137, doi. 10.1007/s13300-024-01669-5
- By:
- Publication type:
- Article